Join our daily newsletter At The Bell to receive exclusive market insights
- Shekel Brainweigh (SBW) enters a trading halt while it plans an upcoming capital raise
- Currently, it is not known how much the company is aiming to raise or where the funds will be spent
- Under the halt, company shares will be paused until Thursday, December 16, or when further details about the raise is released to the market, whichever one comes first
- Shekel is an Israel-based company that develops weighting technology for the healthcare, retail and industrial sectors
- On the market, Shekel last traded at 24 cents per share
Shekel Brainweigh (SBW) has entered into a trading halt while it plans an upcoming capital raise.
So far, there is no information on how much the company is planning to raise or where it will spend the money.
Under the halt, company shares will be paused until Thursday, December 16, or when further details about the raise are released to the market, whichever one comes first.
Shekel is an Israel-based company that develops weighting technology for the healthcare, retail and industrial sectors.
Notably, Its digital weighing technology has been implemented into self-checkout systems.
Shekel Brainweigh said its products allow customers to self-check out in a more convenient way.
Over the year, the company saw revenue growth of 29 per cent in 2021 versus the current year 2020.
From January 1 to November 30, total revenue increased 29 per cent to US$18.2 million (A$25.6) in CY21.
The company is expecting further growth in retail and healthcare segments in Q4 CY21 and into CY22.
On the market, Shekel last traded at 24 cents per share.
